MoneyWorks4Me

Lupin informs about press release

13 Jul 2021 Evaluate

Lupin has informed that it has enclosed a Press Release as regards launch by the Company of Tavaborole Topical Solution, 5% in the US, having received an approval from the US FDA. This considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..